Refine by
Upper Limb Articles & Analysis
18 news found
Executed Partnership with Nippon Shinyaku for the Commercialization and Distribution of CAP-1002 for Duchenne Muscular Dystrophy in the United States Upfront Payment of $30 Million Received in 1 st Quarter Strengthens Cash Position and Extends Cash Runway Positive Phase 2 Results Published in The Lancet Evaluating CAP-1002 in Late-Stage Duchenne Muscular Dystrophy Pivotal Phase 3 Trial ...
Axinesis expands its intensive functional rehabilitation offer We are delighted to announce the launch of our new REAtouch® Lite: the device for decentralized upper-limb rehabilitation in the rehabilitation centre or at home. REAtouch Lite is the portable version of the REAtouch: our device for intensive bimanual functional upper-limb rehabilitation. REAtouch bimanual intensive therapy for ...
ByAxinesis
Robot-assisted therapy (RAT) is of significant interest in early rehabilitation, when neuroplasticity is high but motor control is frequently insufficient for patients to independently practice functional movements. Many patients with stroke experience persistent upper limb (UL) impairments. This single-blind, randomized, controlled trial[i] explored the impact of partially substituting ...
ByAxinesis
One-Year Final Data Highlights Lead Cell Therapy Asset, CAP-1002, for Safety and Efficacy in Slowing Upper Limb and Cardiac Function Deterioration in Patients Data Sets Stage for Pivotal Phase 3 HOPE-3 Clinical Trial Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention ...
CAP-1002 Cell Therapy Programs Pivotal Phase 3, HOPE-3 Trial Initiation Underway- Entered Exclusive Partnership with Nippon Shinyaku for Commercialization and Distribution of CAP-1002 for Duchenne Muscular Dystrophy in United States- Capricor to Receive Upfront Payment of $30 Million with Additional Milestone Payments of up to $705 Million- Phase 2 INSPIRE Top-Line Data Expected by End of ...
BioXtreme is proud to announce a new cooperation agreement was recently signed with Advanced Medical Solutions s.r.o (AMS) from Brno, Czech Republic. The agreement situates AMS as BioXtreme’s representative in the Czech Republic and Slovakia, with exclusive distribution rights for BioXtreme’s neurorehabilitation products and forming connections with hospitals and rehabilitation ...
BioXtreme is proud to announce that a new commercial evaluation agreement was signed with STEPS Budapest Center for Robotic Rehabilitation. The agreement includes a 6- months evaluation period for deXtreme, by the end of which STEPS commits to purchasing the device (pending evaluation criteria are met). BioXtreme has developed a ground-breaking robotic device for motor-learning, based on ...
Villa Beretta Rehabilitation Center and BioXtreme are proud to announce that they have agreed to conduct a joint evaluation project in the hospital’s facility in Costa-Masnaga, Italy. BioXtreme has developed a ground-breaking robotic device for motor-learning, based on innovative error enhancement technology for upper limb rehabilitation from stroke and other neurological injuries. Villa ...
Reuth Rehabilitation Hospital and BioXtreme are proud to announce that they have agreed to conduct a joint clinical trial research project in the hospital’s facility in Tel-Aviv, Israel. BioXtreme has developed a ground-breaking robotic device for motor-learning, based on innovative error enhancement technology for upper limb rehabilitation from stroke and other neurological injuries. ...
University Hospitals Leuven, KU Leuven and BioXtreme are proud to announce that they have agreed to conduct a joint clinical trial research project in the university’s facility in Leuven, Belgium. BioXtreme has developed a ground-breaking robotic device for motor-learning, based on innovative error enhancement technology for upper limb rehabilitation from stroke and other neurological ...
AXINESIS entrusts DESSINTEY with the distribution of its REAplan robot in France With this collaboration, Dessintey proposes a unified offer IVS3 + REAplan® for a complete and intensive upper limb rehabilitation. The upper limb, essential for daily life activities Whether they are the result of a stroke, an orthopaedic trauma or ...
ByAxinesis
MicroTransponder Inc., today announced that the pivotal clinical trial results for the Company's investigational Vivistim® Paired Vagus Nerve Stimulation (VNS) System have been published in The Lancet. Each year in the US, 50-60% of the 658,000 stroke survivors have upper extremity motor deficits that persist for many months to years after their stroke. The Lancet reports that patients ...
BioXtreme is happy to announce a new addition to its management team – Mrs. Tamar Moyal. Tamar will serve as the company’s Sales Manager and will be in charge of establishing sales operations in North America and Europe, including business development, contact with distributors, KOL’s, developing training materials and more. Tamar has more than 30 years of experience in sales ...
BioXtreme is proud to announce that, following our ISO-13485 certification from the Israeli Standards Institution (www.sii.org.il), it has received its CE Marking, based on self declaration. The CE Marking is intended for deXtreme, our upper limb neurorehabiliatation robotic device, meant to treat stroke and other TBI patients with our novel Error Enhancement technology. By this CE Marking we ...
We are proud to announce that BioXtreme has formed a strategic partnership with Jamzone. Located in the Netherlands, Jamzone is an innovation lab, specializing in development of innovative products and services that are cutting-edge in mental, emotional and behavioral healthcare and performance. The first phase of the partnership will focus on the VR and AR environments of deXtreme™ and ...
We are proud to announce that BioXtreme was awarded a R&D grant from the Israel Innovation Authority (coupled with additional investment from our strategic investor) in the amount of $1M. The grant will be used to further develop and improve our groundbreaking solution, deXtreme, as well as develop a future finger grip product (either as a complementary product for deXtreme or an autonomous ...
Nerve transfer surgery has enabled 13 young adults with complete paralysis to regain movement and function in their elbows and hands, according to the largest case series of this technique in people with tetraplegia (paralysis of both the upper and lower limbs), published in The Lancet. During the surgery, Australian surgeons attached functioning nerves above the spinal injury to paralysed ...
MicroTransponder, Inc., (www.microtransponder.com) a privately-held medical device company, is pleased to announce that its successful stroke rehabilitation clinical trial has been published in the prestigious academic journal Stroke. The manuscript, titled "Safety, Feasibility and Efficacy of Vagus Nerve Stimulation (VNS) Paired with Arm Rehabilitation Following Ischemic Stroke" reports clinical ...